122 related articles for article (PubMed ID: 2877867)
1. Indices of noradrenergic function in the central nervous system of seizure-naive genetically epilepsy-prone rats.
Dailey JW; Jobe PC
Epilepsia; 1986; 27(6):665-70. PubMed ID: 2877867
[TBL] [Abstract][Full Text] [Related]
2. Noradrenergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats.
Dailey JW; Mishra PK; Ko KH; Penny JE; Jobe PC
Epilepsia; 1991; 32(2):168-73. PubMed ID: 2004621
[TBL] [Abstract][Full Text] [Related]
3. Abnormalities in norepinephrine turnover rate in the central nervous system of the genetically epilepsy-prone rat.
Jobe PC; Ko KH; Dailey JW
Brain Res; 1984 Jan; 290(2):357-60. PubMed ID: 6692149
[TBL] [Abstract][Full Text] [Related]
4. Effect of repeated seizure experiences on tyrosine hydroxylase immunoreactivities in the brain of genetically epilepsy-prone rats.
Ryu JR; Shin CY; Park KH; Jeon GS; Kim H; Kim W; Dailey JW; Jobe PC; Cho SS; Ko KH
Brain Res Bull; 2000 Dec; 53(6):777-82. PubMed ID: 11179842
[TBL] [Abstract][Full Text] [Related]
5. Noradrenergic abnormalities in the genetically epilepsy-prone rat.
Jobe PC; Mishra PK; Browning RA; Wang C; Adams-Curtis LE; Ko KH; Dailey JW
Brain Res Bull; 1994; 35(5-6):493-504. PubMed ID: 7859107
[TBL] [Abstract][Full Text] [Related]
6. Anticonvulsant effects of intracerebroventricularly administered norepinephrine are potentiated in the presence of monoamine oxidase inhibition in severe seizure genetically epilepsy-prone rats (GEPR-9s).
Mishra PK; Kahle EH; Bettendorf AF; Dailey JW; Jobe PC
Life Sci; 1993; 52(17):1435-41. PubMed ID: 8464344
[TBL] [Abstract][Full Text] [Related]
7. Serotonergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats.
Dailey JW; Mishra PK; Ko KH; Penny JE; Jobe PC
Life Sci; 1992; 50(4):319-26. PubMed ID: 1732702
[TBL] [Abstract][Full Text] [Related]
8. Regional brain abnormalities in norepinephrine uptake and dopamine beta-hydroxylase activity in the genetically epilepsy-prone rat.
Browning RA; Wade DR; Marcinczyk M; Long GL; Jobe PC
J Pharmacol Exp Ther; 1989 Apr; 249(1):229-35. PubMed ID: 2709332
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities in monoamine levels in the central nervous system of the genetically epilepsy-prone rat.
Jobe PC; Laird HE; Ko KH; Ray T; Dailey JW
Epilepsia; 1982 Aug; 23(4):359-66. PubMed ID: 6284498
[TBL] [Abstract][Full Text] [Related]
10. Neurite extension of developing noradrenergic neurons is impaired in genetically epilepsy-prone rats (GEPR-3s): an in vitro study on the locus coeruleus.
Clough RW; Peterson BR; Steenbergen JL; Jobe PC; Eells JB; Browning RA; Mishra PK
Epilepsy Res; 1998 Jan; 29(2):135-46. PubMed ID: 9477146
[TBL] [Abstract][Full Text] [Related]
11. Anticonvulsant effect of enhancement of noradrenergic transmission in the superior colliculus in genetically epilepsy-prone rats (GEPRs): a microinjection study.
Yan QS; Dailey JW; Steenbergen JL; Jobe PC
Brain Res; 1998 Jan; 780(2):199-209. PubMed ID: 9507130
[TBL] [Abstract][Full Text] [Related]
12. Alterations in mRNA expression of systems that regulate neurotransmitter synaptic content in seizure-naive genetically epilepsy-prone rat (GEPR): transporter proteins and rate-limiting synthesizing enzymes for norepinephrine, dopamine and serotonin.
Szot P; Reigel CE; White SS; Veith RC
Brain Res Mol Brain Res; 1996 Dec; 43(1-2):233-45. PubMed ID: 9037538
[TBL] [Abstract][Full Text] [Related]
13. Noradrenergic and serotonergic determinants of seizure susceptibility and severity in genetically epilepsy-prone rats.
Jobe PC; Dailey JW; Reigel CE
Life Sci; 1986 Sep; 39(9):775-82. PubMed ID: 3747729
[TBL] [Abstract][Full Text] [Related]
14. Brain norepinephrine and convulsions in the genetically epilepsy-prone rat: sex-dependent responses to Ro 4-1284 treatment.
Mishra PK; Dailey JW; Reigel CE; Jobe PC
Life Sci; 1988; 42(11):1131-7. PubMed ID: 3347143
[TBL] [Abstract][Full Text] [Related]
15. Thalamic deficiency in norepinephrine release detected via intracerebral microdialysis: a synaptic determinant of seizure predisposition in the genetically epilepsy-prone rat.
Yan QS; Jobe PC; Dailey JW
Epilepsy Res; 1993 Mar; 14(3):229-36. PubMed ID: 8504793
[TBL] [Abstract][Full Text] [Related]
16. Effects of intraventricular locus coeruleus transplants on seizure severity in genetically epilepsy-prone rats following depletion of brain norepinephrine.
Clough RW; Browning RA; Maring ML; Statnick MA; Wang C; Jobe PC
J Neural Transplant Plast; 1994; 5(1):65-79. PubMed ID: 7819373
[TBL] [Abstract][Full Text] [Related]
17. Alterations in spleen norepinephrine and lymphocyte [3H]dihydroalprenolol binding site number in genetically epilepsy-prone rats.
Carr JA; Ortiz KA; Paxton LL; Saland LC; Savage DD
Brain Behav Immun; 1993 Jun; 7(2):113-20. PubMed ID: 8394163
[TBL] [Abstract][Full Text] [Related]
18. Effect of 5,7-dihydroxytryptamine on audiogenic seizures in genetically epilepsy-prone rats.
Statnick MA; Maring-Smith ML; Clough RW; Wang C; Dailey JW; Jobe PC; Browning RA
Life Sci; 1996; 59(21):1763-71. PubMed ID: 8937503
[TBL] [Abstract][Full Text] [Related]
19. Noradrenergic terminal fields as determinants of seizure predisposition in GEPR-3s: a neuroanatomic assessment with intracerebral microinjections of 6-hydroxydopamine.
Wang C; Mishra PK; Dailey JW; Jobe PC; Browning RA
Epilepsy Res; 1994 May; 18(1):1-9. PubMed ID: 8088252
[TBL] [Abstract][Full Text] [Related]
20. Effect of norepinephrine release on adrenoceptors in severe seizure genetically epilepsy-prone rats.
Seo DO; Shin CY; Ryu JR; Cheong JH; Choi CR; Dailey JW; Reith ME; Jobe PC; Ko KH
Eur J Pharmacol; 2000 May; 396(2-3):53-8. PubMed ID: 10822056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
